Medivir AB (publ)
MVRBF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $429 | $592 | $304 | $610 |
| - Cash | $6 | $15 | $14 | $34 |
| + Debt | $16 | $14 | $16 | $44 |
| Enterprise Value | $438 | $591 | $306 | $619 |
| Revenue | $4 | $26 | $14 | $9 |
| % Growth | -82.7% | 83.1% | 59.9% | – |
| Gross Profit | $4 | $26 | $14 | $9 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$85 | -$59 | -$38 | -$115 |
| % Margin | -1,934.3% | -231.2% | -269.9% | -1,317.4% |
| Net Income | -$89 | -$63 | -$43 | -$123 |
| % Margin | -2,013.7% | -247.2% | -305.6% | -1,414.9% |
| EPS Diluted | -1.59 | -1.2 | -1.44 | -4.17 |
| % Growth | -32.5% | 16.7% | 65.5% | – |
| Operating Cash Flow | -$102 | -$49 | -$58 | -$148 |
| Capital Expenditures | -$0 | $0 | -$3 | -$1 |
| Free Cash Flow | -$102 | -$49 | -$61 | -$150 |